Start here if you're new
what it is
CareCloud sells software and back-office help that lets doctors run billing, records, and scheduling in one cloud system.
how it gets paid
Last year Carecloud made $120M in revenue. Revenue cycle management services was the main engine at $54M, or 45% of sales.
why it's growing
Revenue grew 8.7% last year. Revenue was up 177% vs. prior year. EPS was up 75% vs. prior year.
what just happened
CareCloud posted $86M in quarterly revenue and $0.07 EPS, with gross margin at 46.49%.
At a glance
C++ balance sheet — some cracks in the foundation
30/100 earnings predictability — expect surprises
73.5x trailing p/e — you're paying up for this one
16.7% return on capital — nothing to write home about
-$0.28 fy2024 eps est
xvary composite: 41/100 — below average
What they do
CareCloud sells software and back-office help that lets doctors run billing, records, and scheduling in one cloud system.
CareCloud sits inside daily doctor workflows. It serves more than 40,000 healthcare providers with 3,650 employees. Leaving means moving billing, records, and scheduling at the same time, and your clinic hates downtime.
How they make money
$120M
annual revenue · their business grew +8.7% last year
Revenue cycle management services
$54M
Medical practice management
$36M
Professional services and staffing
$30M
The products that matter
AI scribe and documentation
stratusAI
40,000-provider base
It matters because CareCloud wants to sell higher-value software into the same 40,000-provider customer base. This page does not show standalone revenue or adoption numbers yet, so you should treat it as an option on better margins, not a proven engine.
AI upsell
medical billing and claims
Revenue Cycle Management
inside the $96M segment
Most of the $96M software and services bucket runs through billing and claims workflows, and the 46.5% gross margin says this is where operating leverage has to come from.
margin driver
cloud-based patient records
Electronic Health Records
40,000 providers served
EHR creates friction because practices do not casually rip out record systems once workflows are embedded across staff and billing. That is not an unbreakable moat, but it helps keep customers in place.
switching friction
Key numbers
$120M
annual sales
That is the whole business in one number. Every $100 of sales leaves about $9.40 after operating costs.
9.4%
operating margin
You keep $9.40 of every $100 after running the business. That is decent for a small software name.
16.7%
capital return
For every $100 invested in the business, CareCloud gets $16.70 back in operating profit.
1.8
beta
The stock moves about 80% more than the market. Calm is not part of the deal.
Financial health
C++
strength
- balance sheet grade C++ — below average — limited financial resources
- risk rank 3 — safer than 50% of stocks
- price stability 5 / 100
- long-term debt $8M (6% of capital)
C++ — below average. watch for debt servicing and cash burn.
Total return vs. market
Return history isn't available for CCLD right now.
source: institutional data · return history unavailable
What just happened
beat estimates
CareCloud posted $86M in quarterly revenue and $0.07 EPS, with gross margin at 46.49%.
Revenue was up 177% vs. prior year. EPS was up 75% vs. prior year. The absurd part is that the numbers finally look like a real software business.
$86M
revenue
$0.07
eps
46.49%
gross margin
the number that mattered
The $86M quarter matters because it is 177% above last year. That is real momentum, not a rounding error.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is the profit streak breaking before carecloud earns the premium multiple.
med
valuation outruns the operating reality
The snapshot shows trailing P/E readings of 47.7x and 73.5x, while FY26 revenue guidance points to 6.7%–10.0% growth from the $120M base referenced on the page.
That spread leaves little room for a boring year. If margins stop improving, multiple compression does the work instead.
med
preferred dividend arrearages start competing for cash
The company must begin paying dividends on its Series B preferred stock in 2026 to address accumulated arrearages.
That could redirect roughly $2M–$4M a year away from reinvestment, debt flexibility, or support for common shareholders.
med
AI story gets ahead of execution
CareCloud is leaning on stratusAI and a new strategy setup during a CEO transition, but this page does not yet show hard adoption or revenue numbers for that product line.
If AI stays a narrative layer instead of a margin layer, the stock loses one of its clearest arguments for a premium valuation.
A stock priced at 47.7x–73.5x earnings can absorb some mess. It cannot absorb much if revenue only grows 6.7%–10.0% and the profit streak slips.
source: institutional data · regulatory filings · risk analysis
Pay attention to
earnings
Q1 2026 earnings report
Expected May 5, 2026. Zacks forecasts EPS of $0.11. You want the profit streak to continue and commentary that keeps FY26 revenue inside the $128M–$132M range.
mix
software and services growth rate
That bucket grew 9.0% in the disclosed segment data and represents 80% of the mix shown here. If it slows, the premium multiple gets harder to explain.
capital
preferred dividend payments
Series B preferred arrearages become a real cash allocation issue in 2026. Watch timing, size, and whether management frames it as manageable or annoying.
trend
positive GAAP income streak
Four consecutive profitable quarters is the new fact on this page. If that becomes five and six, the story gets stronger. If it breaks, the stock probably loses the benefit of the doubt.
Analyst rankings
earnings predictability
30 / 100
in human-speak, analysts do not see a smooth, easy-to-model earnings profile here.
price stability
5 / 100
That is near the bottom of the scale. You should expect this stock to move like a small cap with a still-forming narrative.
risk rank
3
The underlying business looks less dangerous than the stock action. That distinction matters if you are underwriting both.
source: institutional data
Institutional activity
institutional ownership data for CCLD is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$3
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive